{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:33:31Z","timestamp":1791192811368,"version":"4.1.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3410,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,5]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>In Egypt, schistosomiasis was traditionally the most important public health problem and infection with<\/jats:bold>\n                                 <jats:bold>\n                                    Schistosoma mansoni\n                                 <\/jats:bold>\n                                 <jats:bold>the major cause of liver disease. From the 1950s until the 1980s, the Egyptian Ministry of Health (MOH) undertook large control campaigns using intravenous tartar emetic, the standard treatment for schistosomiasis, as community-wide therapy. This commendable effort to control a major health problem unfortunately established a very large reservoir of hepatitis C virus (HCV) in the country. By the mid-1980s, the effective oral drug, praziquantel, replaced tartar emetic as treatment for schistosomiasis in the entire country. This both reduced schistosomal transmission and disease and interrupted the \u201coccult\u201d HCV epidemic. It was evident when diagnostic serology became available in the 1990s that HCV had replaced schistosomiasis as the predominant cause of chronic liver disease. Epidemiological studies reported a high prevalence and incidence of HCV, particularly within families in rural areas endemic for schistosomiasis. Clinical studies showed 70% to 90% of patients with chronic hepatitis, cirrhosis, or hepatocellular carcinoma had HCV infections. Co-infections with schistosomiasis caused more severe liver disease than infection with HCV alone. Schistosomiasis was reported to cause an imbalance in HCV-specific T-cell responses leading to increased viral load, a higher probability of HCV chronicity, and more rapid progression of complications in co-infected persons. As complications of HCV usually occur after 20 years of infection, the peak impact of the Egyptian outbreak has not yet occurred. Efforts have been initiated by the Egyptian MOH to prevent new infections and complications of HCV in the estimated 6 million infected persons. (Hepatology 2006;43:915\u2013922.)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.21173","type":"journal-article","created":{"date-parts":[[2006,4,20]],"date-time":"2006-04-20T19:30:24Z","timestamp":1145561424000},"page":"915-922","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":195,"title":["Liver disease in Egypt: Hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors"],"prefix":"10.1097","volume":"43","author":[{"given":"Thomas G.","family":"Strickland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-8-20241201","doi-asserted-by":"crossref","first-page":"868","DOI":"10.4269\/ajtmh.1980.29.868","article-title":"Schistosomiasis mansoni in an Egyptian village in the Nile Delta.","volume":"29","author":"AbdelWahab","year":"1980","journal-title":"Am J Trop Med Hyg"},{"key":"R4-8-20241201","first-page":"566","article-title":"The incidence and distribution of human schistosomiasis in Egypt.","volume":"25","author":"Scott","year":"1937","journal-title":"Am J Trop Med Hyg"},{"key":"R5-8-20241201","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(79)90249-6","article-title":"Changing pattern of schistosomiasis in Egypt 1935-79.","volume":"2","author":"AbdelWahab","year":"1979","journal-title":"Lancet"},{"key":"R6-8-20241201","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(99)06527-7","article-title":"The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt.","volume":"355","author":"Frank","year":"2000","journal-title":"Lancet"},{"key":"R7-8-20241201","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4269\/ajtmh.2000.62.88","article-title":"The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates.","volume":"62","author":"ElKhoby","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"R8-8-20241201","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4269\/ajtmh.1993.49.697","article-title":"Is Schistosoma mansoni replacing Schistosoma haematobium in the Fayoum?","volume":"49","author":"AbdelWahab","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"R9-8-20241201","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4269\/ajtmh.2000.62.55","article-title":"The epidemiology of schistosomiasis in Egypt: Fayoum Governorate.","volume":"62","author":"AbdelWahab","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"R10-8-20241201","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4269\/ajtmh.2000.62.2_suppl.10813502","article-title":"The epidemiology of schistosomiasis in Egypt: Minya Governorate.","volume":"62","author":"Gabr","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"R11-8-20241201","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4269\/ajtmh.1989.40.72","article-title":"Characteristic sonographic pattern of schistosomal hepatic fibrosis.","volume":"40","author":"AbdelWahab","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"R12-8-20241201","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4269\/ajtmh.1992.46.403","article-title":"Grading of hepatic schistosomiasis by the use of ultrasonography.","volume":"46","author":"AbdelWahab","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"R13-8-20241201","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pt.2003.09.005","article-title":"Drugs for the control of parasitic diseases: current status and development in schistosomiasis.","volume":"19","author":"Fenwick","year":"2003","journal-title":"Trends Parasitol"},{"key":"R14-8-20241201","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4269\/ajtmh.1994.51.563","article-title":"High seroprevalence of hepatitis C infection among risk groups in Egypt.","volume":"51","author":"AbdelWahab","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"R15-8-20241201","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4269\/ajtmh.1996.54.554","article-title":"High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study.","volume":"54","author":"Darwish","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"R16-8-20241201","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0035-9203(97)90070-5","article-title":"Hepatitis C antibody prevalence in blood donors in different governorates in Egypt.","volume":"91","author":"Arthur","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R17-8-20241201","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/jhep.2000.8438","article-title":"Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence.","volume":"32","author":"AbdelAziz","year":"2000","journal-title":"HEPATOLOGY"},{"key":"R18-8-20241201","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4269\/ajtmh.2000.63.236","article-title":"Hepatitis C in a community in Upper Egypt: I. Crosssectional survey.","volume":"63","author":"Nafeh","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"R20-8-20241201","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/gut.2004.057182","article-title":"Peginterferon (alpha)2b and ribavirin therapy in chronic hepatitis C genotype 4; impact of treatment duration and viral kinetics on sustained viral response.","volume":"54","author":"Kamal","year":"2005","journal-title":"Gut"},{"key":"R21-8-20241201","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/jhep.2001.20797","article-title":"Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity.","volume":"33","author":"Habib","year":"2001","journal-title":"HEPATOLOGY"},{"key":"R22-8-20241201","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4269\/ajtmh.2002.66.633","article-title":"Hepatitis c in a community in Upper Egypt: risk factors for infection.","volume":"66","author":"Medhat","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"R23-8-20241201","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ije\/dyh370","article-title":"Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data.","volume":"34","author":"Magder","year":"2005","journal-title":"Int J Epidemiol"},{"key":"R24-8-20241201","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/hep.20811","article-title":"Intrafamilial transmission of hepatitis C in Egypt.","volume":"42","author":"Mohamed","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R25-8-20241201","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.37.1.105","article-title":"High prevalence of hepatitis C in Egyptian patients with chronic liver disease.","volume":"37","author":"Waked","year":"1995","journal-title":"Gut"},{"key":"R26-8-20241201","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4269\/ajtmh.2002.67.436","article-title":"Role of hepatitis C infection in chronic liver disease in Egypt.","volume":"67","author":"Strickland","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"R27-8-20241201","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0168-8278(97)80036-0","article-title":"Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections.","volume":"26","author":"Angelico","year":"1997","journal-title":"J Hepatol"},{"key":"R28-8-20241201","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4269\/ajtmh.2001.64.147","article-title":"Hepatitis C and cirrhotic liver disease in the Nile delta of Egypt: a communitybased study.","volume":"64","author":"Darwish","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"R29-8-20241201","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004836-200108000-00006","article-title":"The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients.","volume":"33","author":"Hassan","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"R30-8-20241201","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijheh.2005.04.003","article-title":"Association of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt.","volume":"208","author":"Ezzat","year":"2005","journal-title":"Int J Hyg Environ Health"},{"key":"R31-8-20241201","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00004836-200209000-00013","article-title":"Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States.","volume":"35","author":"Hassan","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"R32-8-20241201","first-page":"663","article-title":"M, elEnein AA, AbouZeid M, elFiky A, Abdallah T, Fawzy M, et al. Hepatocellular carcinoma in MansouraEgypt: experience of 385 patients at a single center.","volume":"47","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"R33-8-20241201","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/ije\/dyh183","article-title":"Casecontrol study of nonHodgkins lymphoma and hepatitis C virus infection in Egypt.","volume":"33","author":"Cowgill","year":"2004","journal-title":"Int J Epidemiol"},{"key":"R34-8-20241201","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1136\/gut.35.10.1334","article-title":"Gastrointestinal manifestations of schistosomiasis.","volume":"35","author":"Strickland","year":"1994","journal-title":"Gut"},{"key":"R35-8-20241201","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0016-5085(76)80557-4","article-title":"Hepatitis B surface antigen carrier state in hepatosplenic schistosomiasis.","volume":"71","author":"Lyra","year":"1976","journal-title":"Gastroenterology"},{"key":"R36-8-20241201","first-page":"456","article-title":"HBV exposure and HBsAg positivity rates in schistosomiasis japonica: study in a Philippine community endemic for both infections.","volume":"14","author":"Domingo","year":"1983","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"R37-8-20241201","first-page":"67","article-title":"Chronic hepatitis B in patients with schistosomiasis mansoni.","volume":"86","author":"Bassily","year":"1983","journal-title":"J Trop Med Hyg"},{"key":"R38-8-20241201","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0035-9203(89)90657-3","article-title":"The relationship between uncomplicated schistosomiasis and hepatitis B infection.","volume":"83","author":"Madwar","year":"1989","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R39-8-20241201","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4269\/ajtmh.1991.45.743","article-title":"The impact of endemic schistosomiasis on acute viral hepatitis.","volume":"45","author":"Ghaffar","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"R40-8-20241201","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1034\/j.1600-0676.2000.020004281.x","article-title":"Clinical, virological and histopathological features: longterm followup in patients with chronic hepatitis C coinfected with S. mansoni.","volume":"20","author":"Kamal","year":"2000","journal-title":"Liver"},{"key":"R41-8-20241201","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0168-8278(00)80207-X","article-title":"Interferon therapy in patients with chronic hepatitis C and schistosomiasis.","volume":"32","author":"Kamal","year":"2000","journal-title":"J Hepatol"},{"key":"R42-8-20241201","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.4049\/jimmunol.148.10.3264","article-title":"Infection with Schistosoma mansoni alters Th1Th2 cytokine responses to a nonparasite antigen.","volume":"148","author":"Kullberg","year":"1992","journal-title":"J Immunol"},{"key":"R43-8-20241201","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1073\/pnas.90.3.948","article-title":"Helminth infection results in decreased virusspecific CD8 cytotoxic Tcell and Th1 cytokine responses as well as delayed virus clearance.","volume":"90","author":"Actor","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R44-8-20241201","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1002\/eji.1830241220","article-title":"Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: association of viral persistence with egg granuloma formation.","volume":"24","author":"Actor","year":"1994","journal-title":"Eur J Immunol"},{"key":"R45-8-20241201","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","article-title":"Analysis of successful immune responses in persons infected with hepatitis C virus.","volume":"191","author":"Lechner","year":"2000","journal-title":"J Exp Med"},{"key":"R46-8-20241201","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection.","volume":"194","author":"Thimme","year":"2001","journal-title":"J Exp Med"},{"key":"R47-8-20241201","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/gast.2001.27024","article-title":"Acute hepatitis C without and with schistosomiasis: correlation with hepatitis Cspecific CD4() Tcell and cytokine response.","volume":"121","author":"Kamal","year":"2001","journal-title":"Gastroenterology"},{"key":"R48-8-20241201","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1086\/323352","article-title":"Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni.","volume":"184","author":"Kamal","year":"2001","journal-title":"J Infect Dis"},{"key":"R49-8-20241201","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1086\/382278","article-title":"Kinetics of intrahepatic hepatitis C virus (HCV)specific CD4 T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.","volume":"189","author":"Kamal","year":"2004","journal-title":"J Infect Dis"},{"key":"R50-8-20241201","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-3024.2005.00762.x","article-title":"Schistosoma infection inhibits cellular immune responses to core HCV peptides.","volume":"27","author":"Farid","year":"2005","journal-title":"Parasite Immunol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.21173","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200605000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:02:10Z","timestamp":1733058130000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200605000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.21173","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}